Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
PLASMA KALLIKREIN BINDING PROTEINS

No-Receipt date 2019-01615 - 22/04/2019
No-Filing date 20190800022 - 22/04/2019
No-Granting date 8000783 - 06/10/2020
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 8/2019 - 25/09/2019
Gazette No-Publication date of granted patent 10/2020 - 16/11/2020
Expiration date 27/11/2033
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status VALID
Priorities US292614 P06/01/2010/US
Active Substance of Supplementary Certificates LANADELUMAB

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20180403052

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1371617 TAKEDA PHARMACEUTICAL COMPANY LIMITED 1-1, DOSHOMACHI 4-CHOME, CHUO-KU,OSAKA-SHI, OSAKA, JAPAN JAPAN

Inventors
CodeFirstnameSurname
2311678 SEXTON, DANIEL, J.
2311679 VISWANATHAN, MALINI

Representatives
CodeFirstnameSurnameAddressTownZip
3089NIKOLAOSLYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"STOURNARI 37ATHINA (ATTIKIS)10682

Contact
CodeFirstnameSurnameAddressTownZipCountry
7915NIKOLAOSLYMPERISSTOURNARI 37ATHINA (ATTIKIS)10682 GREECE

Owners History
Date Description Comments Data before modification Data after modification
14/09/2021 Μεταβίβαση (7g802) Α.Π.10890, ΑΡ.ΥΠ.4337384/21, ΔΝΥ.1472, ΚΩΔ.ΠΛΗΡ.3458 926631 Dyax Corp. 300 Shire Way ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Lexington, MA 02421 1371617 Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome, Chuo-ku, ΙΑΠΩΝΙΑ Osaka-shi, Osaka, JAPAN

Title Instruments

Payments history
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).